Edesa Biotech (EDSA) Research & Development (2013 - 2026)
Edesa Biotech (EDSA) recorded Research & Development of $3.96 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 321.5% from $939,067 a year earlier.
Powered by 
Analysis
Edesa Biotech (EDSA) Research & Development (2013 - 2026) Analysis & Trends
On a TTM basis, Edesa Biotech's Research & Development came in at $7.25 million as of Jun 30, 2026, up 184.5% year-over-year; for FY2025 (ended Sep 30, 2025), it was $3.67 million, up 27.3% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of 2.0% (FY2020 to FY2025).
- Across earlier fiscal years, Research & Development came in at $2.88 million in FY2024 (-39.9%), $4.79 million in FY2023 (-64.0%), $13.34 million in FY2022 (-25.7%) and $17.95 million in FY2021 (+439.0%).
- The fiscal Q3 2026 figure is the highest quarterly Research & Development since fiscal Q3 2022.
- On a year-over-year basis, Research & Development rose in four of the last six quarters, with growth averaging 38.9%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 321.5% in fiscal Q3 2026, against a decline of 89.1% in fiscal Q4 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Edesa Biotech | 26.08 Mn | -19.46 Mn | - | 3.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.96 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 939,067.00 |
| Mar 31, 2025 | 484,306.00 |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | 103,867.00 |
| Jun 30, 2024 | 897,305.00 |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 704,458.00 |
| Sep 30, 2023 | 953,399.00 |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 1.46 Mn |
| Dec 31, 2022 | 1.36 Mn |
| Sep 30, 2022 | 1.79 Mn |
| Jun 30, 2022 | 4.55 Mn |
| Mar 31, 2022 | 3.04 Mn |
| Dec 31, 2021 | 3.95 Mn |
| Sep 30, 2021 | 4.13 Mn |
| Jun 30, 2021 | 4.46 Mn |
API Access
Edesa Biotech Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();